Catalyst Wire Dossier Catalyst Wire Dossier

Lactiplantibacillus plantarum LM1001

Lactiplantibacillus plantarum LM1001 · Lactomason Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lactiplantibacillus plantarum LM1001, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Lactiplantibacillus Plantarum LM1001 on Muscle Strength in Older Adults [NA]

See pricing